News on diagnostics for respiratory pathogens, including influenza, coronavirus, and more.
The tool has been applied to determine the pathogenic cause of hemorrhagic fever, and is powering a new test for respiratory disease pathogens.
While point-of-care molecular testing of patients with respiratory illness wasn't associated with lower antibiotic use, patients tested had shorter drug courses.
The firm said that its test is the first on the market to detect RSV infection at the point of care in 13 minutes or less.
A team of researchers in the UK used a two-stage approach to tie the rare variants to disease risk.
Bio-Techne will provide a bioanalytical assay for the group to assess and validate as a bioanalytical method for clinical trial recruitment.
